ATERA Signs R&D Agreement with InMed

Vancouver, BC – July 10, 2017 – InMed Pharmaceuticals, Inc. (“InMed” or the « Company ») (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce it has entered into a research and development collaboration with ATERA SAS of France, a leading tissue engineering company…


CellSystems Biotechnologie Vertrieb GmbH and ATERA SAS announce a close collaboration

CellSystems Biotechnologie Vertrieb GmbH (Troisdorf, Germany) and ATERA SAS (Villeneuve-Loubet, France) announce a close collaboration for the commercialization of the epiCS® human skin models, including human epidermis, tanned epidermis and full thickness skin. Both companies will work together to boost the sales of the epiCS® skin models and related products as well as testing applications by co-marketing cross sectorial.